Feiolix has three different pathways that increase GLP-1 secretion in the body. GLP-1 helps to increase satiety, delay gastric emptying, and regulate blood sugar levels. GLP-1 agonists have been researched thoroughly for their weight management potential.
Feiolix contains high concentrations of bioactives which impact glucose levels in the bloodstream by increasing insulin secretion, inhibiting glucagon release (prevent blood sugar levels from getting too high), and sensitising receptors to glucose, decreasing insulin resistance.
Click here to download file
NZ Feijoas contain 114% more abscisic acid than any other fruit. Abscisic acid is one of our key bioactives that naturally stimulates GLP-1 production, amongst other things. Our proprietary processing protects the abscisic acid and passes its benefits on to Feiolix consumers.
Click here to download file
Feiolix and it’s bioactives’:
Feiolix contains 3 key bioactives that helps with metabolic regulation
- Abscisic Acid
- Increases energy usage by increasing thermogenesis in humans.
- Binds to the GLUT4 in skeletal and adipose cells. ABA sensitises GLUT4 to glucose in the blood stream and increases the amount of glucose absorbed from blood stream
- ABA binds to LANCL2 and increases insulin secretion and ultimately absorption of glucose from the blood stream.
- ABA triggers the secretion of GLP-1
- Inhibits NFkB which leads to less disruptive hunger signalling and leading to feelings of satiety
- Polyphenols (Specifically ellagitannins and catechins)
- Converted to bioavailable urolithins, which promote insulin and GLP-1 secretion
- Bind to the bitter taste receptors in the intestine promoting GLP-1 secretion
- Inhibit NFkB to lead to feelings of satiety
- Dietary Fibre (Xylans and Xyloglucans)
- Provide food to the microbiome that is converted into SCFA’s
- Triggers the release of GLP-1 and PYY
- PYY inhibits ghrelin , a hunger promoting hormone
Read more about the mechanism of actions here:
Feiolix®
is a patented ingredient
A method of lowering serum glucose
A method of lowering blood pressure
Preventing or lower obesity
Ameliorating symptoms of diabetes
Continuous Blood Glucose Monitor Market Acceptance Testing
Read here about how our most recent testing for Feiolix on blood glucose levels. 20 participants consumed Feiolix daily, whilst wearing a CGM, to see how it impacted their blood glucose levels!
Feiolix and Clinical
Feiolix has also been tested in adults with diabetes. Thirty-two participants consumed 150mg extract (equiv. 2300mg powder) of Feiolix daily for 12 weeks. Outcomes of Feiolix consumption were:
- Feijoa extract significantly decreased (p < 0.05) in fasting blood glucose and haemoglobin A1c (HbA1c).
- The magnitude of change seen with HbA1c (decrease by 0.86) is considered by FDA as clinically significant as pharmaceuticals for diabetes treatment are approved with changes of greater decrease than 0.5.
- Cholesterol and triglycerides also decreased significantly
- Trial participants in the Feiolix extract group showed no significant changes in the standard liver enzyme, serum creatine, albumin, and urea. These data show no toxicity is observed in the feijoa extract.
Read more about our clinical work:
Why Feiolix® is your best choice?
Clinically proven effectiveness
Market Acceptance Testing Platform
Fantastic taste
Long Shelf-life (36 months)
Noticeable improvement in satiety after one dose!
It All Starts With an email!
For any kind of queries, Please contact us
+64 9 520 0831
Level 1, 272 Parnell Road, Parnell, Auckland 1052, New Zealand
info@anagenix.com
